Sub menu

 

 

Annual charge exemptions (ACE) dataset

View annual charge exemptions (ACE) based on a sponsor declaring $0 turnover.

In order to ensure transparency about the availability of therapeutic goods in Australia, all entries in the ARTG that had not commenced generating turnover and were exempt from annual charges under the ACE scheme in previous financial years, are published on the TGA website annually under the authority of subsection 61 (5C) of the Therapeutic Goods Act 1989.

Exemptions published are for the 2024-2025 financial year.

You can view previous financial years exemptions on Trove.

Last updated
Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

20197 result(s) found, displaying 15451 to 15475

  • Pro repair (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Arnicare declaring $0 turnover in that period.

  • Probe, <specify> (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Baxter Healthcare Pty Ltd declaring $0 turnover in that period.

  • Probe, <specify> (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.

  • Probe, <specify> (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.

  • Probe, surgical, arthroscopy (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.

  • ProBioFit (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Plexus Australia Pty Ltd declaring $0 turnover in that period.

  • ProBioFit (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Plexus Australia Pty Ltd declaring $0 turnover in that period.

  • Probiotic (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Australian Antarctic Ocean Bio-Technology Pty Ltd declaring $0 turnover in that period.

  • ProbioX (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Dr Joseph Ahrens Pty Ltd trading as ATM International declaring $0 turnover in that period.

  • Procare (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Pharmametics Products A Division of Max Biocare Pty Ltd declaring $0 turnover in that period.

  • Procare Diamond (2024-25)

    2024-25
    Annual charge exemption
    Exempt from annual charge in 2024-25 due to Pharmametics Products A Division of Max Biocare Pty Ltd declaring $0 turnover in that period.
Last updated